Abstract
One hundred and eighty-eight patients with myelomatosis, 166 of whom had multiple myelomatosis, were studied to assess the prognostic significance of age, sex, mode of clinical presentation, presence of anaemia, azotaemia and abnormal cells in the peripheral blood at the time of diagnosis.
The generalized disease was rapidly fatal in many of these unselected patients. Women survived longer than men and the young slightly longer than the old.
Of the laboratory findings, only a raised blood urea (greater than 60 mg/100 ml) was associated with a statistically poorer prognosis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexanian R., Haut A., Khan A. U., Lane M., McKelvey E. M., Migliore P. J., Stuckey W. J., Jr, Wilson H. E. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. JAMA. 1969 Jun 2;208(9):1680–1685. doi: 10.1001/jama.208.9.1680. [DOI] [PubMed] [Google Scholar]
- Bergsagel D. E., Griffith K. M., Haut A., Stuckey W. J., Jr The treatment of plasma cell myeloma. Adv Cancer Res. 1967;10:311–359. doi: 10.1016/s0065-230x(08)60081-0. [DOI] [PubMed] [Google Scholar]
- Broad A. F., Godlee J. N., Emery E. W., Prankerd T. A. The management of myelomatosis. Postgrad Med J. 1968 Oct;44(516):803–806. doi: 10.1136/pgmj.44.516.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FEINLEIB M., MACMAHON B. Duration of survival in multiple myeloma. J Natl Cancer Inst. 1960 Jun;24:1259–1269. [PubMed] [Google Scholar]
- Galton D. A., Peto R. A progress report on the Medical Research Council's therapeutic trial in myelomatosis. Br J Haematol. 1968 Sep;15(3):319–320. [PubMed] [Google Scholar]
- Hobbs J. R. Growth rates and responses to treatment in human myelomatosis. Br J Haematol. 1969 Jun;16(6):607–617. doi: 10.1111/j.1365-2141.1969.tb00441.x. [DOI] [PubMed] [Google Scholar]
- INNES J., NEWALL J. Myelomatosis. Lancet. 1961 Feb 4;1(7171):239–245. doi: 10.1016/s0140-6736(61)91420-9. [DOI] [PubMed] [Google Scholar]
- JOHANSEN H., VIDEBAEK A. Prognosis in eighty cases of multiple myeloma. Dan Med Bull. 1956 Sep;3(6):174–176. [PubMed] [Google Scholar]
- MARTIN N. H. The incidence of myelomatosis. Lancet. 1961 Feb 4;1(7171):237–239. doi: 10.1016/s0140-6736(61)91419-2. [DOI] [PubMed] [Google Scholar]
- Rivers S. L., Patno M. E. Cyclophosphamide vs melphalan in treatment of plasma cell myeloma. JAMA. 1969 Feb 17;207(7):1328–1334. [PubMed] [Google Scholar]